Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Evaluation of Patients with HAM/TSP Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on Evaluation of Patients with HAM/TSP conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Evaluation of Patients with HAM/TSP Clinical research trials and Evaluation of Patients with HAM/TSP healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including Evaluation of Patients with HAM/TSP. Evaluation of Patients with HAM/TSP Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a Evaluation of Patients with HAM/TSP clinical trial. Test subjects oftentimes recieve the best healthcare possible for their Evaluation of Patients with HAM/TSP condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.

Home > "E" Clinical Trials Conditions > Evaluation of Patients with HAM/TSP

Evaluation of Patients with HAM/TSP



Evaluation of Patients with HAM/TSP

For Condition: HTLV-I Infection,Tropical Spastic Paraparesis
Status: Recruiting
Sponsor(s): National Institute of Neurological Disorders and Stroke (NINDS) ,
Synopsis: The purpose of this study is to obtain blood samples from three groups of subjects; 1. Patients infected with human T cell leukemia virus type-1 (HTLV-1) and clinical symptoms of HTLV-1 associated myelopathy (HAM) / tropical spastic paraparesis (TSP) 2. Family members of patients infected with human T cell leukemia virus type-1 (HTLV-1) and clinical symptoms of HTLV-1 associated myelopathy (HAM) / tropical spastic paraparesis (TSP) 3. Patients who have inconclusive blood test results on the presence of HTLV-1 The specimens will be used evaluate immune system function and to measure levels of the virus.
Details: Human T-lymphotropic virus type-I-associated myelopathy / tropical spastic paraparesis (HAM/TSP) is a rare neurologic disorder that affects less than 5% of patients infected with the HTLV-I virus. The purpose of this protocol is to study the natural history of HAM/TSP with emphasis on defining its virological and immunological changes with respect to clinical progression.
Eligibility:
Study Type:  Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: - Positive HTLV-I EIA or Western blot positive for HTLV-I bands. - Willingness to participate in the protocol evaluations and procedures. EXCLUSION CRITERIA: - Unwillingness or inability participate in the protocol evaluations and procedures. - The presence of any medical, social, or psychiatric conditions that in the opinion of the investigator may affect the safety of the patients or compliance with the protocol. - Children under the age of 18 are excluded.
Total Enrollment: 100

Location and Contact Information:

National Institute of Neurological Disorders and Stroke (NINDS) *Recruiting*
Bethesda,  Maryland,  20892
United States
Recruiting Patient  and Public Liaison Office 1-800-411-1222


Additional Information:
Study ID Numbers:  980047;  98-N-0047
Study Start Date: December 23, 1997
Record last reviewed: January 14, 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001778

Other Htlv-I Infection Studies:
1. Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients with HTLV-1-Associated Myelopathy (HAM)

2. Evaluation of Patients with HAM/TSP

3. Assessment of Patients with Multiple Sclerosis (MS)

4. Anti-Tac for Treatment of Leukemia

Related Studies:

Other HTLV-I Infection Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials

Evaluation of Patients with HAM/TSP
Modify your Search

  Other HTLV-I Infection Clinical Trials
  Other Maryland Clinical Trials
  Other Bethesda Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103